GLAND PHARMA Q2 RESULTS
Gland Pharma shares jump 4% as Q2 profit jumps 58%, revenue rises 23% YoY
Gland Pharma shares rose 3.89% after reporting strong Q2 FY27 results, with revenue growing 23% and net profit jumping 58% year-on-year. The stock touched a 52-week high of Rs 3,345, supported by robust CDMO growth, improved margins, new product launches and increased US regulatory approvals.
Sai Life Sciences shares jump 9%, multibagger stock rallies 19% in 3 days after Q2 results. Why Jefferies hiked target price
Sai Life Sciences shares hit a fresh 52-week high on Monday after strong Q2 results and bullish brokerage commentary. Jefferies retained its Buy rating and raised its target price to Rs 2,050, citing healthy CRO and CDMO growth, a strengthening pipeline and improved earnings prospects.
Divi's Labs Q2 Results: PAT surges 64% YoY to Rs 1,127 crore; revenue jumps 35%
Divi's Laboratories has achieved a remarkable profit surge of 63.6% year-on-year for the September quarter of FY27, driven by a 35.4% increase in operational revenue, totaling Rs 3,676 crore. The company's total income reached Rs 3,770 crore in Q2FY27, while the first half of the fiscal year saw total earnings hit Rs 6,907 crore.
Tata Steel Q2 Results: Profit rises 16% YoY to Rs 3,700 crore, revenue up 11%; Noel Tata to retire as director
Tata Group's Tata Steel has reported a 16.2% year-on-year increase in profit after tax for Q2FY27. Consolidated revenue from operations grew by 11.5% year-on-year, reaching over Rs 65,436 crore. The profit after tax for the quarter was around Rs 3,700 crore, compared to the previous year's amount. Additionally, Noel Naval Tata will retire from his position effective November 11, 2026.
Stocks in news: Bharti Airtel, LIC, Titan, ONGC, Bharti Hexacom, Glenmark Pharma and Astral
Indian equity markets continued their upward trend, highlighted by the Nifty 50 gaining 576 points. Bharti Airtel, LIC, and Titan Company reported strong profit increases for the September quarter. ONGC also posted a substantial rise in consolidated profit compared to last year. In contrast, Glenmark Pharmaceuticals faced a significant decline in net profit this quarter. Overall, corporate developments are influencing investor sentiment as markets react to earnings reports.
Britannia Industries Q2 Results: Profit rises 11% YoY to Rs 726 crore, revenue grows 16%
Britannia Q2 Results: FMCG major Britannia Industries on Thursday reported a 10.8% year-on-year (YoY) increase in consolidated net profit to Rs 726 crore for the September quarter of FY27 (Q2FY27), compared with Rs 655.06 crore in the corresponding quarter of the previous fiscal.
- Go To Page 1
Titan Q2 Results: Profit jumps 54% YoY to Rs 1,722 crore; total income up 25%
Titan Q2 Results: Titan Company reported a 54% year-on-year rise in consolidated net profit to Rs 1,722 crore in Q2 FY27, driven by strong demand across jewellery, watches and eyewear. Revenue growth remained broad-based despite a shift in the festive calendar, while international jewellery operations expanded with the addition of Damas..
LIC Q2 Results: Profit jumps 20% YoY to Rs 12,115 crore, NPI grows 16%
LIC Q2 Results: Life Insurance Corporation of India (LIC), the country's largest insurer, reported a nearly 20% rise in consolidated net profit to Rs 12,114.78 crore for the September quarter on Thursday, supported by strong growth in premium income and higher investment earnings.
Bharti Airtel Q2 Results: Net profit jumps 31% YoY to Rs 8,887 crore; revenue up 17%; ARPU rises to Rs 271
Bharti Airtel Q2 Results: Bharti Airtel reported a 31% year-on-year (YoY) increase in net profit to Rs 8,887.5 crore for the September quarter (Q2FY27), compared with Rs 6,791.6 crore in the corresponding quarter last fiscal.
M&M Q2 Results: Profit rises 25% YoY to Rs 4,588 crore, revenue grows 25%
M&M Q2 Results: Revenue from operations grew 25.4% YoY to Rs 57,514.98 crore in Q2FY27, against Rs 45,885.40 crore reported in the year-ago period.
Pills are paying off! Pharma stocks lead 2026 rally with up to 112% return
In 2026, India's pharmaceutical stocks are making headlines with impressive year-to-date gains. This surge is driven by strong domestic demand alongside enhanced profitability from new product launches. Notable players like Laurus Labs and Gland Pharma have recorded remarkable returns, topping 100%. Amid challenges faced by other sectors, the pharmaceutical field demonstrates resilience. Analysts are optimistic but advise exercising caution regarding potential market volatility and the durability of this sector's performance.
LG Electronics India Q2 Results: Net profit jumps 27% YoY to Rs 489 crore; stock climbs 5%
LG Electronics India reported a net profit of Rs 489 crore for the second quarter of FY27, which is an increase. The profit jumped 27% year-on-year compared to Rs 389 crore from the same period last year. Revenue from operations totaled Rs 7,380 crore, showing a rise of 19.5% from Rs 6,174 crore previously. Following the earnings release, shares of LG India surged nearly 5% on the BSE exchange.
BSE Q2 Results: Net profit surges 45% YoY to Rs 809 crore; revenue jumps 34%
BSE on Wednesday reported a 44.9% year-on-year rise in consolidated net profit to Rs 809.15 crore for the second quarter of FY27 (Q2FY27), compared with Rs 558.43 crore in the corresponding period last year (Q2FY26).
Lenskart Q2 Results: Profit zooms 122% YoY to Rs 227 crore; revenue grows 36%
Lenskart Solutions achieved a net profit of Rs 227.08 crore in Q2FY27, reflecting a 122.1% YoY increase. Revenue from operations rose to Rs 2,845.03 crore, marking a 35.7% YoY growth. Product margin improved to 64% compared to 63.4% in the same quarter last year. The company added 165 new stores in Q2FY27, enhancing its active store count to 3,624.
Emcure Pharma shares hit 10% upper circuit after FY27 guidance hike; Jefferies raises target price by 8%
Emcure Pharma shares hit a 10% upper circuit after strong Q2 FY27 results prompted the company to raise its full-year growth guidance. Brokerages turned more positive, citing robust international business, improving domestic growth and a strong product pipeline.
Emcure Pharma Q2 Results: Profit jumps 29% to Rs 325 crore
Emcure Pharmaceuticals Ltd has posted a remarkable consolidated net profit of Rs 325.06 crore for the September quarter, reflecting substantial growth. Revenue surged from Rs 2,269.82 crore to Rs 2,820.47 crore during this period, with international operations increasing by 34 per cent. Additionally, domestic revenue witnessed an 11.1 per cent rise, as company leaders expressed confidence in sustaining this positive trend through the latter half of FY27.
NSE Q2 Results: Profit jumps 23% to Rs 2,578 crore, revenue rises 9%
NSE Q2 Results: The National Stock Exchange of India (NSE) reported a 23% year-on-year (YoY) increase in its consolidated profit after tax (PAT) to Rs 2,578 crore in the second quarter of FY27 (Q2FY27), compared with Rs 2,098 crore in the corresponding quarter of the previous fiscal year (Q2FY26).
SBI Q2 Results: Standalone profit rises 14% YoY to Rs 23,038 crore, NII jumps 15%
SBI Q2 Results: Net interest income in the reporting period increased 15% YoY to Rs 49,143 crore.
ITC Q2 Results: Profit falls 18% to Rs 4,229 crore, revenue rises 5%
ITC Q2 Results: ITC Ltd reported an 18.5% decline in consolidated net profit for the September quarter on Monday as a sharp fall in earnings from its cigarette business weighed on overall profitability despite strong growth in its FMCG, agriculture and paper businesses.
Mold-Tek Packaging shares surge 17% as Q2 FY 27 profit jumps 35% YoY to Rs 21 crore
Mold-Tek Packaging shares surged nearly 17% after the company reported a 35.5% YoY rise in Q2 FY27 net profit and 30.5% revenue growth. Strong pharma and FMCG packaging volumes supported performance, while new product launches and expansion plans strengthened its growth outlook.
Reliance Industries Q2 Results: Profit shoots up 41% YoY to Rs 25,548 crore, revenue surges 29%
Reliance Industries Q2 Results: Mukesh Ambani-led Reliance Industries Ltd (RIL) on Friday reported a 41% year-on-year (YoY) growth in consolidated net profit to Rs 25,548 crore for the September quarter of FY27, compared with Rs 18,165 crore in the corresponding period last year.
Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional charges
Sun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported by strong growth in its domestic formulations business and emerging markets.
RIL Q2 Results Preview: Profit outlook brightens as O2C business set to drive growth
Reliance Industries is expected to report 15-17% year-on-year growth in September-quarter EBITDA, driven by a sharp recovery in its oil-to-chemicals business. Brokerages expect stronger refining margins, higher throughput and a weaker rupee to offset subdued retail and oil and gas performance. Investors will track O2C profitability, Jio Platforms’ earnings and retail margins as RIL announces results.
Trent Q2 Results: Cons profit jumps 25% YoY to Rs 468 crore; revenue climbs 22%
Trent Q2 Results: Trent reported a 25.3% year-on-year rise in Q2 FY27 consolidated net profit to Rs 468 crore, while revenue grew 21.9% to Rs 5,873 crore. EBITDA rose 29.6% to Rs 1,054 crore, with margins improving to 18.2%. The retailer expanded its footprint across Westside, Zudio and other lifestyle concepts.
IndiGo Q2 Results: Loss narrows YoY to Rs 1,879 crore; revenue rises 26%
IndiGo Q2 Results: Budget airline IndiGo reported narrowing of its consolidated loss to Rs 1,879 crore in the second quarter of FY27, compared with Rs 2,582 crore in the year-ago quarter. However, the loss widened from Rs 237 crore posted in the preceding June quarter.
Adani Ports Q2 Results: Net profit jumps 17% YoY to Rs 3,622 crore; revenue up 24%
Adani Ports Q2 Results: Adani Ports reported a 17% year-on-year rise in Q2 FY27 net profit to Rs 3,622 crore, while revenue grew 24% to Rs 11,340 crore. The company raised its FY27 revenue and EBITDA guidance by Rs 1,000 crore each and increased its capex guidance by Rs 3,000 crore, citing strong first-half performance.
Larsen & Toubro Q2 Results: Profit surges 33% YoY to Rs 5,202 crore, revenue grows 16%
L&T Q2 Results: Larsen & Toubro announced significant financial results for the quarter ended September 30, 2026. The company reported a 33% increase in consolidated profit after tax compared to the previous year. Consolidated revenue also grew by 16%, driven by strong performance across various sectors. Additionally, L&T achieved its highest quarterly order inflow and saw substantial international participation in its orders.
Cipla Q2 Results: Profit falls 35% YoY to Rs 878 crore; revenue slips 2%
Cipla reported a 35% drop in consolidated net profit for Q2FY27, which stood at Rs 878 crore. The company also experienced a 2.4% year-on-year decline in revenue from operations, totaling Rs 7,404 crore. Additionally, a significant 26.7% decrease in EBITDA resulted in a lower margin of 18.7%. Nonetheless, Cipla's One India division demonstrated growth across various segments, while the company aims to enhance productivity and innovate its product offerings.
Paytm Q2 Results: Profit rockets 976% YoY to Rs 226 crore, revenue jumps 28%
Paytm Q2 Results: Fintech major Paytm on Monday reported 976% year-on-year (YoY) growth in its consolidated net profit at Rs 226 crore. The same stood at Rs 21 crore in the year-ago quarter. Revenue from operations in the reporting period rose 28% YoY to Rs 2,648 crore.
Load More
